chr19-54636509-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001081637.3(LILRB1):c.1669G>A(p.Glu557Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000287 in 1,611,270 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001081637.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LILRB1 | NM_001081637.3 | c.1669G>A | p.Glu557Lys | missense_variant | 14/15 | ENST00000324602.12 | NP_001075106.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LILRB1 | ENST00000324602.12 | c.1669G>A | p.Glu557Lys | missense_variant | 14/15 | 5 | NM_001081637.3 | ENSP00000315997.7 |
Frequencies
GnomAD3 genomes AF: 0.000211 AC: 32AN: 151596Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000301 AC: 75AN: 249264Hom.: 1 AF XY: 0.000312 AC XY: 42AN XY: 134662
GnomAD4 exome AF: 0.000295 AC: 431AN: 1459674Hom.: 1 Cov.: 39 AF XY: 0.000288 AC XY: 209AN XY: 726142
GnomAD4 genome AF: 0.000211 AC: 32AN: 151596Hom.: 0 Cov.: 31 AF XY: 0.000149 AC XY: 11AN XY: 74018
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 26, 2021 | The c.1669G>A (p.E557K) alteration is located in exon 14 (coding exon 13) of the LILRB1 gene. This alteration results from a G to A substitution at nucleotide position 1669, causing the glutamic acid (E) at amino acid position 557 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at